Addressing Counterfeit Medicines and Community Risk: Insights from South African Spaza Shops

Main Article Content

  Michael Mncedisi Willie
  Athandile Hadebe

Abstract

Background: Governance and regulatory enforcement in South Africa reveal complex interactions among formal legal frameworks, operational capacity, and informal market practices. While deliberative processes, such as public consultations on the draft Traditional Courts Regulations, demonstrate transparency and inclusivity, interventions in the healthcare sector are often reactive, triggered by crises such as food contamination fatalities and the sale of illegal medicines. This contrast underscores disparities in institutional capacity and sectoral prioritisation.
Objectives: This paper investigated regulatory gaps and enforcement challenges in informal medicine markets, with a focus on spaza shops. The focus was on structural, operational, and social factors influencing the circulation of counterfeit, expired, and improperly stored medicines, and explores how governance, public service delivery, and community dynamics interact to affect public health outcomes.
Methods: A qualitative case-study approach guided this research, focusing on the analysis of secondary data sources and qualitative literature. Purposive selection of documents and reports included government communications, regulatory guidelines, parliamentary hearing transcripts, media coverage, and peer-reviewed studies, ensuring that the sources provided rich insights into governance, regulatory enforcement, and informal pharmaceutical practices.
Findings: Systemic gaps exist between regulatory intent and operational reality. Although legal frameworks restrict the dispensing of scheduled medicines to licensed pharmacies and authorised health professionals, widespread non-compliance persists in township spaza shops.
Conclusion: Effective mitigation of counterfeit and illegally sold medicines requires an integrated, multi-dimensional approach that strengthens regulatory oversight, secures supply chains, mobilises community engagement, and leverages technological monitoring. The proposed Integrated Regulatory-Community Framework for Counterfeit Medicines in Spaza Shops (IRCF-CMSS) aligns formal legislation with practical enforcement and social realities, promoting sustained compliance, enhanced public safety, and institutional trust.

Downloads

Download data is not yet available.

Article Details

How to Cite
Willie, M. M., & Athandile Hadebe. (2026). Addressing Counterfeit Medicines and Community Risk: Insights from South African Spaza Shops. Indonesian Journal of Health Research and Development, 4(1), 53–63. https://doi.org/10.58723/ijhrd.v4i1.593
Section
Literature Review

References

A’aqoulah A, El-Metwally AA, Al Khateeb B, Alammari D, Alshahrani A, Aldubikhi A, Alsulami A, Fatani F, Innab N. Challenges and opportunities of complexity theory in health care systems. J Taibah Univ Med Sci. 2025;20(4):429–434. https://doi.org/10.1016/j.jtumed.2025.06.006

Abdunasir E, Sosengo T, Amare F. Assessment of awareness and attitude towards counterfeit medicines among pharmacy professionals working in community drug retail outlets in Harar town, Ethiopia. OJPSR. 2021;11(1). https://doi.org/10.36811/ojpsr.2020.110010

Adigwe OP, Onavbavba G, Wilson DO. Challenges associated with addressing counterfeit medicines in Nigeria: An exploration of pharmacists’ knowledge, practices, and perceptions. Integr Pharm Res Pract. 2022;11:177–186. https://doi.org/10.2147/IPRP.S387354

Akyildirim E, Corbet S, Nicolau JL, Oxley L. Understanding reputational disaster during economic crises: Evaluating aviation sector response differentials. Tour Manag. 2025;106:105028. https://doi.org/10.1016/j.tourman.2024.105028

Callanan A. How to check and identify fake medicines. Pfizer Global Security. 2021. https://www.pfizer.com

Caxton Local Media. Local shop owner caught with unlicensed products [Internet]. Soweto Urban: The Citizen; 2026 Feb 28 [cited 2026 Feb 28]. Available from: https://www.citizen.co.za/news/local-news/

Chabalenge B, Sahota T, Ermolina I, Tanna S. Substandard and falsified medicines in Africa: healthcare systems challenges, supply chain issues, regulatory challenges and strategies to increase access to quality medicines. Front Pharmacol. 2025;16:1708784. https://doi:10.3389/fphar.2025.1708784

Department of Justice and Constitutional Development. Public has until 13 February to comment on draft Traditional Courts Regulations. 2025 Dec 26.

Eid J, Hansen AL, Andreassen N, Espevik R, Brattebø G, Johnsen BH. Developing local crisis leadership – A research and training agenda. Front Psychol. 2023;14:1041387. https://doi.org/10.3389/fpsyg.2023.1041387

Feeney AJ, Goad JA, Flaherty GT. Global perspective of the risks of falsified and counterfeit medicines: A critical review of the literature. Travel Med Infect Dis. 2024;61:102758. https://doi.org/10.1016/j.tmaid.2024.102758

Gauteng Department of Health. Gauteng Health warns shops against the sale of scheduled medication without a licence. 2024 Nov 7. www.gov.za

Hornberger J, Hodges S, Chitukutuku E. Fake-talk and the spaza shop: A fake food furore and the spectre of public health emergencies in South Africa. Matatu J Afr Media Stud. 2023;10(3):71–136. https://doi.org/10.17157/mat.10.3.7136

Katerere DR. Fake medicines are a dangerous threat in Africa: 3 ways to spot them. The Conversation. 2025. https://theconversation.com

Koko M. GP Health looks to SAHPRA to establish task team tackling illegal sale of medicine at spaza shops. 2024 Nov 9. https://www.ewn.co.za

Laird Y, Manner J, Baldwin L, Hunter R, McAteer J, Rodgers S, Williamson C, Jepson R. Stakeholders’ experiences of the public health research process: time to change the system? Health Res Policy Syst. 2020;18:83. https://doi.org/10.1186/s12961-020-00599-5

Moshoeshoe RJ, Enslin GM, Katerere DR. An exploratory assessment of the legislative framework for combating counterfeit medicines in South Africa. J Pharm Policy Pract. 2022;15(1). https://doi.org/10.1186/s40545-021-00387-8

Mourad N, Haddad C, Sacre H, Al Tawil S, Zeenny RM, Younes S, et al. Knowledge, practices, and recognition ability of counterfeit medicines among Lebanese community pharmacists during concurrent national crises. Sci Rep. 2026;16:109. https://doi:10.1038/s41598-025-00000-x

Ofori-Parkus S, Park SE. I (don’t) want to consume counterfeit medicines: Exploratory study on the antecedents of consumer attitudes toward counterfeit medicines. BMC Public Health. 2022;22:13529. https://doi.org/10.1186/s12889-022-13529-7

Ofori-Parku SS. Fighting the global counterfeit medicines challenge: A consumer-facing communication strategy in the US is an imperative. J Glob Health. 2022;12:03018. https://doi.org/10.7189/jogh.12.03018

Organisation for Economic Co-operation and Development (OECD). Trade in Counterfeit Pharmaceutical Products. Paris: OECD Publishing; 2020. https://www.oecd.org

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, … Moher D. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71

Pal E, Merchant L, Koffi AK, Mehta R, Rusatira JC, Kubiak L. Assessing knowledge, attitudes, and practices and demand-side interventions for combating substandard and falsified medicines: A scoping review. J Pharm Policy Pract. 2025;18(1):2550369. https://doi.org/10.1080/20523211.2025.2550369

Parliamentary Monitoring Group. Medicines and Related Substances Amendment Bill: Public hearings. 2008 Aug 5. https://pmg.org.za/committee-meeting/861/

Pharmaceutical Society of South Africa. Limits on dispensing and sales of prescription and over the counter medicines [PDF]. 2020 Mar 24. https://www.pssa.org.za

Quttainah MA, Pathak A, Soni T. Configurations of corporate governance mechanisms and sustainable development: a review [Internet]. Indian J Corp Gov. 2025 Apr 21;18(1). Available from: https://doi.org/10.1177/09746862251327829

Rigby BP, Dodd-Reynolds CJ, Oliver EJ. The understanding, application and influence of complexity in national physical activity policy-making. Health Res Policy Syst. 2022;20:59. https://doi.org/10.1186/s12961-022-00857-9

Rotea CC, Ploscaru AN, Bocean CG, Vărzaru AA, Mangra MG, Mangra GI. The link between HRM practices and performance in healthcare: the mediating role of the organizational change process [Internet]. Healthcare (Basel). 2023 Apr 26;11(9):1236. Available from: https://doi.org/10.3390/healthcare11091236

Snyder H. Literature review as a research methodology: An overview and guidelines. J Bus Res. 2019;104:333–339. https://doi:10.1016/j.jbusres.2019.07.039

South African Health Products Regulatory Authority (SAHPRA). SA’s health emergency: Efforts to tackle unhealthy medication sales [Television broadcast]. eNCA, DStv Channel 403; 2024 Nov 14.

Swami Gurunand Jnanathapaswi. Thematic analysis & coding: An overview of the qualitative paradigm. In: An introduction to social science research. APH Publishing Corporation; 2021. https://doi.org/10.6084/m9.figshare.17159249

Tate JA, Happ MB. Qualitative secondary analysis: A case exemplar. J Pediatr Health Care. 2017;32(3):308–312. https://doi:10.1016/j.pedhc.2017.09.007

Tshikalange S. Scheduled medication sold illegally at shops: Selling scheduled medication without a licence places lives at risk. TimesLIVE. 2024 Nov 8. https://www.timeslive.co.za/news/south-africa/

Willie MM. A review of the diversity and characteristics of Spaza shops in South Africa. Golden Ratio of Data in Summary. 2025;5(2):44–46. https://doi.org/10.52970/grdis.v5i2.467

World Health Organization (WHO). Substandard and falsified medical products. 2024 Dec 3. https://www.who.int